Business Context and Reporting Period
This Form 8-K was filed by Obalon Therapeutics, Inc. (noting the metadata reference to Vyome Holdings, Inc.) on February 12, 2019. The report details a specific financing event under Item 8.01 Other Events.
Key Financial Metrics
The filing discloses the following debt metrics:
- Total Loan Facility: $20.0 million aggregate principal amount.
- Recent Draw: $10.0 million (second tranche) drawn on February 12, 2019.
- Remaining Availability: $0 (no additional amount available).
- Interest Rate: Variable, equal to the greater of Prime Rate + 1.5% or 5.0% per annum.
- Maturity Date: July 9, 2022.
- Repayment Terms: Interest-only through July 9, 2019; followed by 36 equal monthly installments of principal and interest starting August 9, 2019.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or overall liquidity beyond the specific loan details.
Material Changes
The material change reported is the full utilization of the $20.0 million Loan and Security Agreement with Pacific Western Bank, originally dated July 9, 2018. The company has now drawn the entire facility, leaving no further borrowing capacity under this agreement.
Outlook, Risks, and Contingencies
The company is classified as an emerging growth company. The loan agreement allows for full prepayment at any time with no additional cost. No specific forward-looking guidance, risk factors, or unusual items were disclosed in this specific filing beyond the debt obligation terms.
Investor Verification Checklist
- Verify the current Prime Rate to calculate the exact interest expense on the $20.0 million outstanding balance.
- Confirm the company's cash position to ensure it can meet the interest-only payments through July 2019 and the subsequent principal repayments.
- Review the original July 9, 2018 Loan Agreement for any covenants or default triggers not summarized in this 8-K.
- Clarify the relationship between the registrant name "Obalon Therapeutics, Inc." and the metadata reference "Vyome Holdings, Inc."